Semaglutide vs Tirzepatide
Research & educational use only. This content is not medical advice. Consult a qualified healthcare professional before using any peptide compound.
Semaglutide and Tirzepatide are both glp1 peptides that come up together constantly. This is a side-by-side comparison on the data that actually matters — evidence tier, FDA status, human trials, and how to source each safely — not hype. It is for research and educational purposes only.
Semaglutide vs Tirzepatide: side-by-side
| Semaglutide | Tirzepatide | |
|---|---|---|
| Evidence tier | Tier 1 | Tier 1 |
| FDA status | FDA Approved | FDA Approved |
| Human RCTs | 10 | 8 |
| Subjects enrolled | 20,000 | 13,000 |
| Animal studies | 12 | 15 |
| Category | glp1 | glp1 |
| Half-life | Approximately 7 days, enabling once-weekly administration. | Approximately 5 days, enabling once-weekly administration. |
| Community logs | 1 | 1 |
Key differences
Both Semaglutide and Tirzepatide sit at the same evidence tier (Tier 1), so neither has a clear edge in how strong its human data is. Both are FDA approved for specific indications.
Semaglutide has 10 human trials on record (20,000 subjects) versus Tirzepatide's 8 (13,000 subjects). Evidence tiers are a shorthand for how strong that human data is — see our guide to understanding peptide evidence tiers for how to weigh them.
What is Semaglutide?
Semaglutide is a GLP-1 receptor agonist approved by the FDA (as Ozempic and Rybelsus for type 2 diabetes, and Wegovy for chronic weight management). It is supported by large phase 3 randomized controlled trials, including cardiovascular outcome data. It is a prescription medication; gray-market research-chemical… Full Semaglutide breakdown →
What is Tirzepatide?
Tirzepatide is a dual GIP and GLP-1 receptor agonist approved by the FDA (as Mounjaro for type 2 diabetes and Zepbound for chronic weight management). It is supported by large phase 3 randomized controlled trials demonstrating significant glycemic and weight outcomes. It is a prescription medication; non-prescription… Full Tirzepatide breakdown →
Where to buy Semaglutide or Tirzepatide safely
Both are sold by research-chemical suppliers, not pharmacies, so the source matters as much as the compound. Before buying either, vet sellers on third-party lab testing and enforcement history in the ranked directory of trusted peptide sellers — or jump straight to vetted sources for Semaglutide or Tirzepatide. PeptidesHub does not sell either compound.
Frequently asked questions
Semaglutide and Tirzepatide are both glp1 peptides. Both Semaglutide and Tirzepatide sit at the same evidence tier (Tier 1), so neither has a clear edge in how strong its human data is. Both are FDA approved for specific indications. See each compound's full evidence breakdown for the underlying studies.